Unlock instant, AI-driven research and patent intelligence for your innovation.

Novel compounds useful as s100-inhibitors

The technology of a compound, R16, is applied in the field of new compounds that can be used as S100-inhibitors, which can solve the problems of unknown exact role of S100A9

Active Publication Date: 2017-02-15
ACTIVE BIOTECH AB
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] Although many possible biological functions of S100A9 have been proposed, the exact role of S100A9 in inflammation, cancer and other diseases remains unknown

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel compounds useful as s100-inhibitors
  • Novel compounds useful as s100-inhibitors
  • Novel compounds useful as s100-inhibitors

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0437] The preparation of the compounds according to the invention is well within the capabilities of a person of ordinary skill in the art. For example, compounds of formula (I) can be prepared in a reaction sequence as generally illustrated in Reaction Scheme 1 . Thus, in a general process for the preparation of compounds of formula (I) as defined herein, first in the presence of an organic base such as pyridine or triethylamine in a suitable solvent medium such as DMF, DMSO or N-methylpyrrolidine reaction of a primary amide 1 with an alkyl 3,3,3-trifluoro-2-oxopropionate 2, where R' is an alkyl group such as C1-C3 alkyl such as methyl, followed by addition of a reagent such as Sulfuryl chloride or oxalyl chloride to provide the "acyl imide intermediate" of general formula 3.

[0438] Acyl imide 3 is then reacted with aminobenzimidazole 4 in a suitable solvent medium such as DMF, DMSO or N-methylpyrrolidine to provide compounds of formula (I), wherein R A、 R A、 R B , R ...

Embodiment 1

[0711] 6-chloro -N- [10,11-Dimethyl-4-oxo-3-(trifluoromethyl)-2,5,7-triazatricyclo[6.4.0.0 2,6 ]-dodeca-1(8),6,9,11-tetraen-3-yl]pyridine-2-carboxamide (ABR 239471)

[0712]To a stirred solution of 6-chloropyridine-2-carboxamide (1.00 g, 13.0 mmol) in DMF (8 mL) under argon was added pyridine (1.05 mL, 13.0 mmol) and 3,3,3- Ethyl trifluoro-2-oxo-propionate (1.73 mL, 13.0 mmol). The reaction mixture was stirred at room temperature for 1 hour, then thionyl chloride (0.95 mL, 13.0 mmol) was added dropwise. The reaction mixture was stirred at room temperature for an additional 16 hours, then concentrated to provide the imide intermediate. The amidoimide intermediate was dissolved in DMF (5 mL) and added to 5,6-dimethyl-1H-1,3-benzodiazol-2-amine (2.03 g, 13.0 mmol) in DMF (7 mL), followed by the addition of triethylamine (1.80 mL, 13.0 mmol). The reaction mixture was stirred at room temperature for 4 hours. The reaction was diluted with brine (25 mL) and extracted with EtOAc...

Embodiment 2

[0714] N -[10,11-Dichloro-4-oxo-3-(trifluoromethyl)-2,5,7-triazatricyclo[6.4.0.0 2,6 ]dodeca-1(12),6,8,10-tetraen-3-yl]-6-fluoropyridine-2-carboxamide (ABR 239472)

[0715] To a solution of 6-fluoropyridine-2-carboxamide (700 mg, 4.75 mmol) in DMF (7 mL) under argon was added ethyl 3,3,3-trifluoro-2-oxopropanoate ( 629 µL, 4.75 mmol) and pyridine (383 µL, 4.75 mmol). The reaction mixture was stirred at room temperature for 1 hour, then thionyl chloride (344 µL, 4.75 mmol) was added dropwise. Stirring was continued for an additional 2.5 hours, then the reaction was concentrated to provide the imide intermediate. The resulting acyl imide intermediate was dissolved in DMF (5 mL), then added to 5,6-dichloro-1H-1,3-benzodiazol-2-amine (519 mg, 2.57 mmol) in DMF (5 mL) solution. Triethylamine (0.35 ml, 2.56 mmol) was added and the reaction mixture was stirred at room temperature for 2 hours. The reaction was diluted with brine (30 mL) and extracted with EtOAc (2 x 50 mL). The...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A compound of formula (I) or a pharmaceutically acceptable salt thereof and a pharmaceutical composition comprising the compound. The compound is an inhibitor of interactions between S100A9 and interaction partners such as RAGE, TLR4 and EMMPRIN and as such is useful in the treatment of disorders such as cancer, autoimmune disorders, inflammatory disorders and neurodegenerative disorders.

Description

[0001] field of invention [0002] The present invention relates to novel N-(2-oxo-3-(trifluoromethyl)-2,3-dihydro-1H-benzo[d]imidazo[1,2-a]imidazol-3-yl ) amide derivatives, pharmaceutical compositions of these derivatives and their use as medicines. More specifically, the present invention relates to such derivatives for use in the treatment of cancer, autoimmune disorders, inflammatory disorders and neurodegenerative disorders. [0003] Background of the invention [0004] S100A9 belongs to the S100-family of calcium-binding proteins and has been recognized as an attractive new therapeutic target for the treatment of eg autoimmunity, inflammatory diseases, neurodegenerative diseases and cancer. Other S100 proteins have diverse roles in many different biological processes and are associated with many diseases including cancer, cardiomyopathy, atherosclerosis, Alzheimer's disease and inflammatory diseases. Twenty-one human genes, including S100A9, are located in the chromoso...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D487/04A61K31/4188A61K31/454A61K31/506A61P35/00A61P29/00A61P37/06A61P25/28
CPCC07D487/04A61P25/28A61P29/00A61P35/00A61P37/06A61P43/00A61K31/4184A61K31/4188
Inventor U.维尔马D.利贝里M.埃克布拉德M.拜因布里奇S.伊斯特J.哈格拉夫N.普雷沃斯特
Owner ACTIVE BIOTECH AB